These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26718163)

  • 1. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Psychosocial Care.
    Tong A; Mallett A; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):590-594.e5. PubMed ID: 26718163
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Diet and Lifestyle Management.
    Campbell KL; Rangan GK; Lopez-Vargas P; Tong A
    Semin Nephrol; 2015 Nov; 35(6):572-581.e17. PubMed ID: 26718161
    [No Abstract]   [Full Text] [Related]  

  • 4. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Polycystic Liver Disease.
    Savige J; Mallett A; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):618-622.e5. PubMed ID: 26718168
    [No Abstract]   [Full Text] [Related]  

  • 5. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.
    Rangan GK; Alexander SI; Campbell KL; Dexter MA; Lee VW; Lopez-Vargas P; Mai J; Mallett A; Patel C; Patel M; Tchan MC; Tong A; Tunnicliffe DJ; Vladica P; Savige J
    Nephrology (Carlton); 2016 Aug; 21(8):705-16. PubMed ID: 26511892
    [No Abstract]   [Full Text] [Related]  

  • 6. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetics and Genetic Counseling.
    Patel C; Tchan M; Savige J; Mallett A; Tong A; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):550-556.e1. PubMed ID: 26718158
    [No Abstract]   [Full Text] [Related]  

  • 7. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Screening for Polycystic Kidney Disease.
    Rangan GK; Lee VW; Alexander SI; Patel C; Tunnicliffe DJ; Vladica P
    Semin Nephrol; 2015 Nov; 35(6):557-564.e6. PubMed ID: 26718159
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction to the KHA-CARI Guidelines on ADPKD.
    Rangan GK; Savige J
    Semin Nephrol; 2015 Nov; 35(6):521-3. PubMed ID: 26718154
    [No Abstract]   [Full Text] [Related]  

  • 9. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis.
    Tchan M; Savige J; Patel C; Mallett A; Tong A; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):545-549.e2. PubMed ID: 26718157
    [No Abstract]   [Full Text] [Related]  

  • 10. KHA-CARI Autosomal Dominant Kidney Disease Guideline: Management of Chronic Pain.
    Savige J; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):607-611.e3. PubMed ID: 26718166
    [No Abstract]   [Full Text] [Related]  

  • 11. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Imaging Approaches for Diagnosis.
    Mai J; Lee VW; Lopez-Vargas P; Vladica P
    Semin Nephrol; 2015 Nov; 35(6):538-544.e17. PubMed ID: 26718156
    [No Abstract]   [Full Text] [Related]  

  • 12. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Intracranial Aneurysms.
    Lee VW; Dexter MA; Mai J; Vladica P; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):612-617.e20. PubMed ID: 26718167
    [No Abstract]   [Full Text] [Related]  

  • 13. Autosomal dominant polycystic kidney disease: a case study.
    Phillips A
    Nephrol Nurs J; 2009; 36(1):41-7. PubMed ID: 19271623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of chronic kidney disease. Prevalence of anxiety and depression in autosomal dominant polycystic kidney disease.
    Pérez-Dominguez T; Rodríguez-Pérez A; García-Bello MA; Buset-Ríos N; Rodríguez-Esparragón F; Parodis-López Y; Rodríguez-Pérez JC;
    Nefrologia; 2012 May; 32(3):397-9. PubMed ID: 22592426
    [No Abstract]   [Full Text] [Related]  

  • 15. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Renal Stone Disease.
    Mallett A; Patel M; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):603-606.e3. PubMed ID: 26718165
    [No Abstract]   [Full Text] [Related]  

  • 16. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Monitoring Disease Progression.
    Mai J; Lee VW; Lopez-Vargas P; Vladica P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):565-571.e18. PubMed ID: 26718160
    [No Abstract]   [Full Text] [Related]  

  • 17. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Pharmacological Management.
    Mallett A; Lee VW; Mai J; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):582-589.e17. PubMed ID: 26718162
    [No Abstract]   [Full Text] [Related]  

  • 18. Genes and geneticization? The social construction of autosomal dominant polycystic kidney disease.
    Cox SM; Starzomski RC
    New Genet Soc; 2004 Aug; 23(2):137-66. PubMed ID: 15460614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
    Lee VW; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):595-602.e12. PubMed ID: 26718164
    [No Abstract]   [Full Text] [Related]  

  • 20. Nurse-led peer support group: experiences of women with polycystic ovary syndrome.
    Percy CA; Gibbs T; Potter L; Boardman S
    J Adv Nurs; 2009 Oct; 65(10):2046-55. PubMed ID: 19686401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.